Omega-3 Fatty Acid Supplementation, Pro-Resolving Mediators, and Clinical Outcomes in Maternal-Infant Pairs

Autor: Katherine Rilett, Samuel Zoucha, Caleb Cave, Rebecca Johnson, Tara M. Nordgren, Corrine Hanson, Ann L. Anderson Berry, Sai Sujana Maddipati, Matthew Van Ormer, Elizabeth McGinn, Harriet Appeah, Kara Weishaar, Elizabeth Elliott
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
Neonatal intensive care unit
specialized pro-resolving lipid mediator
Pregnancy
High-Risk

specialized pro-resolving lipid mediator (SPM)
Anti-Inflammatory Agents
Reproductive health and childbirth
Immunologic
Pregnancy
Neonatal
Surveys and Questionnaires
Infant Mortality
Medicine
chemistry.chemical_classification
Pediatric
Omega-3
Nutrition And Dietetics
Nutrition and Dietetics
Fatty Acids
Pregnancy Outcome
omega-3 fatty acid
Prenatal Care
docosahexaenoic acid
Fetal Blood
Diet Records
3. Good health
Docosahexaenoic acid
Biomarker (medicine)
Female
pregnancy
lcsh:Nutrition. Foods and food supply
Adult
fetal health
medicine.medical_specialty
Docosahexaenoic Acids
lcsh:TX341-641
Article
resolvins
03 medical and health sciences
Food Sciences
Adjuvants
Immunologic

Clinical Research
Internal medicine
Fatty Acids
Omega-3

Complementary and Integrative Health
Humans
docosahexaenoic acid (DHA)
Adjuvants
Omega 3 fatty acid
Nutrition
030109 nutrition & dietetics
business.industry
Prevention
fungi
Infant
Newborn

Intensive Care
Fatty acid
Infant
Lipid signaling
Perinatal Period - Conditions Originating in Perinatal Period
medicine.disease
Newborn
030104 developmental biology
Endocrinology
chemistry
Dietary Supplements
Omega 3 fatty acid supplementation
Intensive Care
Neonatal

High-Risk
business
Food Science
Zdroj: Nutrients, Vol 11, Iss 1, p 98 (2019)
Nutrients, vol 11, iss 1
Nordgren, Tara M; Anderson Berry, Ann; Van Ormer, Matthew; Zoucha, Samuel; Elliott, Elizabeth; Johnson, Rebecca; et al.(2019). Omega-3 Fatty Acid Supplementation, Pro-Resolving Mediators, and Clinical Outcomes in Maternal-Infant Pairs.. Nutrients, 11(1), 98-98. doi: 10.3390/nu11010098. UC Riverside: Retrieved from: http://www.escholarship.org/uc/item/5970b90f
Nutrients
Volume 11
Issue 1
ISSN: 2072-6643
Popis: Omega (n)-3 fatty acids are vital to neonatal maturation, and recent investigations reveal n-3 fatty acids serve as substrates for the biosynthesis of specialized pro-resolving lipid mediators (SPM) that have anti-inflammatory and immune-stimulating effects. The role SPM play in the protection against negative maternal-fetal health outcomes is unclear, and there are no current biomarkers of n-3 fatty acid sufficiency. We sought to ascertain the relationships between n-3 fatty acid intake, SPM levels, and maternal-fetal health outcomes. We obtained n-3 fatty acid intake information from 136 mothers admitted for delivery using a food frequency questionnaire and measured docosahexaenoic acid (DHA)-derived SPMs resolvin D1 (RvD1) and RvD2 in maternal and cord plasma. We found significantly elevated SPM in maternal versus cord plasma, and increased SPM levels were associated with at-risk outcomes. We also identified that increased DHA intake was associated with elevated maternal plasma RvD1 (p = 0.03
R2 = 0.18) and RvD2 (p = 0.04
R2 = 0.20) in the setting of neonatal intensive care unit (NICU) admission. These findings indicate that increased n-3 fatty acid intake may provide increased substrate for the production of SPM during high-risk pregnancy/delivery conditions, and that increased maternal plasma SPM could serve as a biomarker for negative neonatal outcomes.
Databáze: OpenAIRE